Aristo Bio-Tech IPO vs Eastern Logica Infoway IPO

Comparison between Aristo Bio-Tech IPO and Eastern Logica Infoway IPO.

IPO Details

Aristo Bio-Tech IPO is a SME Fixed Price IPO proposed to list at NSE SME while Eastern Logica Infoway IPO is a SME Fixed Price proposed to list at BSE SME.

Issue Size and Price

The total issue size of Aristo Bio-Tech IPO is up to ₹12.40 Cr whereas the issue size of the Eastern Logica Infoway IPO is up to ₹16.07 Cr. The final issue price of Aristo Bio-Tech IPO is ₹72.00 per share and of Eastern Logica Infoway IPO is ₹225.00 per share.

 Aristo Bio-Tech IPOEastern Logica Infoway IPO
Face Value₹10 per share₹10 per share
Issue Price (Final)₹72.00 per share₹225.00 per share
Discount (Retail)₹0.00 per share₹0.00 per share
Market Lot Size1600 shares600 shares
Fresh Issue Size17,21,600 shares6,25,200 shares
Fresh Issue Size (Amount)up to ₹12.40 Crup to ₹14.07 Cr
OFS Issue Size0 shares88,800 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹2.00 Cr
Issue Size Total17,21,600 shares7,14,000 shares
Issue Size Total (Amount)up to ₹12.40 Crup to ₹16.07 Cr

IPO Timetable

Aristo Bio-Tech IPO opens on Jan 16, 2023, while Eastern Logica Infoway IPO opens on Jan 05, 2023. The closing date of Aristo Bio-Tech IPO and Eastern Logica Infoway IPO is Jan 19, 2023, and Jan 09, 2023, respectively.

 Aristo Bio-Tech IPOEastern Logica Infoway IPO
Issue OpenJan 16, 2023Jan 05, 2023
Issue CloseJan 19, 2023Jan 09, 2023
Basis Of Allotment (Tentative)Jan 24, 2023Jan 12, 2023
Initiation of Refunds (Tentative)Jan 25, 2023Jan 13, 2023
Credit of Share (Tentative)Jan 27, 2023Jan 16, 2023
Listing date (Tentative)Jan 30, 2023Jan 17, 2023

Financials & KPIs

Aristo Bio-Tech IPO P/E ratio is 9.46, as compared to Eastern Logica Infoway IPO P/E ratio of 24.09.

 Aristo Bio-Tech IPOEastern Logica Infoway IPO
Financials

Company Financials (Restated)

Period Ended30 Sep 202231 Mar 202231 Mar 202131 Mar 2020
Assets108.6977.0081.4287.85
Total Income129.07166.03167.23201.24
Profit After Tax2.591.461.081.01
NET Worth17.4314.8413.3812.31
Reserves and Surplus12.449.858.397.31
Total Borrowing29.3625.4822.2519.71
Amount in ₹ Crore

Company Financials (Restated Consolidated)

Period Ended30 Sep 202231 Mar 202231 Mar 202131 Mar 2020
Assets125.62126.64103.2484.91
Total Income305.04615.58447.03498.83
Profit After Tax1.332.852.341.82
NET Worth36.0334.7031.2628.33
Reserves and Surplus33.8532.5229.1126.23
Total Borrowing56.9559.6844.1429.32
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)100%100%
Promoter Shareholding (Post-Issue)73.37%73.59%
P/E Ratio9.4624.09
Market Cap₹49.02 Cr.₹64.14 Cr.
ROE29.268.22
ROCE35.6420.34
Debt/Equity5.101.72
EPS₹2.93₹13.24
RoNW108.22

Shares Offered

In the Aristo Bio-Tech IPO Retail Individual Investors (RII) are offered 8,60,800 shares while in Eastern Logica Infoway IPO retail investors are offered 8,60,800 shares. Qualified Institutional Buyers (QIB) are offered in Aristo Bio-Tech IPO and 0 shares in Eastern Logica Infoway IPO.

 Aristo Bio-Tech IPOEastern Logica Infoway IPO
Anchor Investor Reservation0 shares
Market Maker Reservation91,200 shares39,000 shares
QIB0 shares
NII8,60,800 shares3,57,000 shares
RII8,60,800 shares3,57,000 shares
Employee0 shares
Total17,21,600 shares7,14,000 shares

Bids Received (Subscription)

Aristo Bio-Tech IPO subscribed 217.72x in total, whereas Eastern Logica Infoway IPO subscribed 1.74x.

 Aristo Bio-Tech IPOEastern Logica Infoway IPO
NII (times)285.84x1.92x
RII (times)149.59x1.56x
Total (times)217.72x1.74x

Compare with others

Compare: